Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with StockholdersKellner Group Urges Stockholders of AIM Immunotech to Vote ...

Researchers have shown how genetic defects in Toxoplasma gondii are rescued if co-infected with normal parasites, thanks to ...

Future Medicine examines long COVID across SARS-CoV-2 variants, focusing on variant-specific clinical features, pathogenesis, and implications for treatment. The study highlights that recent variants ...

A groundbreaking study published in Nature Medicine gives insight into what an HIV cure could look like during infancy ...

Participants had a median age of 54 at enrollment and two-thirds (67.4%) were female. Most participants (90%) had ...

In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small ...

CatalYm today announced new findings from its ongoing Phase 1/2a study as well as preclinical research, highlighting the ...

The variant, present in the NFKB1 gene and common in the Aymara community, could help guide treatment decisions, researchers ...

Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT) ...

Inhibiting TLR7, an immune signaling protein, may help preserve the protective layer surrounding nerve fibers in the brain ...

BBMP and the state health department will kick off a 100-day campaign to raise awareness and treat Tuberculosis in Bengaluru, ...

Request To Download Free Sample of This Strategic Report @ The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing ...